Table of Contents

Special Issue on Harnessing Artificial Intelligence for Personalized Breast Cancer Treatment Guest Editor: Professor Zefei Jiang, Department of Oncology, Chinese PLA General Hospital, Beijing, China

• Editorial

  • Open Access

    Artificial intelligence empowering precision diagnosis and treatment of breast cancer: advancing global clinical practice with regional insights

    Zefei Jiang

    Cancer Biology & Medicine March 2026, 23 (3) 311-313; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0018
  • Open Access

    Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide

    Michael Gnant

    Cancer Biology & Medicine March 2026, 23 (3) 314-319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0674
  • Open Access

    Precision immunotherapy for breast cancer: from biomarkers to clinical practice

    Jie Mei, Kai Yang, Xinkang Zhang, Xiang Huang and Yongmei Yin

    Cancer Biology & Medicine March 2026, 23 (3) 320-326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0815
  • Open Access

    Advances in TROP2-targeted antibody-drug conjugates for breast cancer therapy: into the new era

    Kuikui Jiang and Shusen Wang

    Cancer Biology & Medicine March 2026, 23 (3) 327-337; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0504

• Perspective

  • Open Access

    Protocol and statistical designs in classic clinical research—toripalimab series trial analysis

    Yingjian He, Li Bian and Zefei Jiang

    Cancer Biology & Medicine March 2026, 23 (3) 338-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0759

• Reviews

  • Open Access

    The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer

    Yilin Chen, Ye Qin, Man Yang, Wei Li, Minyi Cheng, Yuhong Huang, Teng Zhu and Kun Wang

    Cancer Biology & Medicine March 2026, 23 (3) 343-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0655
  • Open Access

    Artificial intelligence in breast cancer: applications and advancements

    Jianbin Li and Zefei Jiang

    Cancer Biology & Medicine March 2026, 23 (3) 363-373; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0704

• Original Articles

  • Open Access

    Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer

    Yaxin Zhao, Han Wang, Ying Wang, Yizhou Jiang, Xin Hu and Zhiming Shao

    Cancer Biology & Medicine March 2026, 23 (3) 374-391; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0691
  • Open Access

    Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors

    Mingzhu Liu, Qingxi Chen, Luoling Zhang, Yunxuan Zhou, Ning Wen, Jin Jin, Junchao Cai, Shicheng Su, Jiang Li and Qiyi Zhao

    Cancer Biology & Medicine March 2026, 23 (3) 392-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0775
  • Open Access

    Virtual histology imaging of lymph nodes via dynamic full-field optical coherence tomography and deep learning to differentiate metastasis

    Shuwei Zhang, Houpu Yang, Yiyin Zhang, Xiaoxian Li, Jin Zhao, Yuanyuan Zhang, Ping Xue, Hua Kang, Hongchuan Jiang, Wenhui Ren and Shu Wang

    Cancer Biology & Medicine March 2026, 23 (3) 418-429; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0747
  • Open Access

    Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study

    Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu

    Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771